Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
about
Clodronate: new directions of useManagement of osteoporosis and associated quality of life in post menopausal women.Adherence to osteoporosis medications after patient and physician brief education: post hoc analysis of a randomized controlled trialGallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts.Treatment persistence with once-monthly ibandronate and patient support vs. once-weekly alendronate: results from the PERSIST studyThe role of counselling and other factors in compliance of postmenopausal osteoporotic patients to alendronate 70 therapyPharmacological treatment of osteoporosis for people over 70.Raloxifene for older women: a review of the literatureEvaluation of persistence and adherence to teriparatide treatment in patients affected by severe osteoporosis (PATT): a multicenter observational real life study.Possible alendronate-induced polyarticular synovitis.Real-world effects of once vs greater daily inhaled corticosteroid dosing on medication adherenceFirst Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates.Differences in outcomes between cholecalciferol and ergocalciferol supplementation in veterans with inflammatory bowel disease.A decreasing trend in fall-related hip fracture incidence in Victoria, Australia.Understanding patient compliance and persistence with osteoporosis therapy.Dose-Intensity of Bisphosphonates and the Risk of Osteonecrosis of the Jaw in Osteoporosis Patients
P2860
Q26775773-CFC9C852-0756-4979-A15E-D8FC95E361E6Q33791246-EAFA3AE1-0EDE-4B98-B1EF-41EE1E66F807Q33914033-B72A7C75-4E90-4534-9DBD-529A14C007E7Q34078767-49708694-20CB-40ED-938F-887959EA29BDQ35105035-0EEA9B5B-1F3C-4A64-8348-A720F82D6425Q36829073-8CAE7351-D5A9-4201-BAE8-3CB02AED6B79Q36868372-FBD97249-7375-489A-B3B5-55E547ED0707Q36892891-01E2EB33-14B3-4523-BFA1-CA3F3311C535Q37008062-126EBBF7-35D7-47C3-9DA8-7F6E268FBB21Q37093610-14EF6810-5EDF-4184-A462-417038EABC3AQ37149647-851A6431-71AC-4D93-91CA-D4A19B4B5CD7Q37638700-A9D2846D-03A7-4020-B641-2F3E1E470826Q37974672-9F57DAD3-2626-46D0-88F4-4AD68880E631Q45346225-8DA7EED2-74F8-4040-AF25-820774501A08Q50629816-B5BA35EF-1DC0-4AAA-81F1-9785DE089762Q57214584-A4149E60-8C09-4CD0-A783-4A4425980F21
P2860
Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
@ast
Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
@en
type
label
Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
@ast
Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
@en
prefLabel
Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
@ast
Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
@en
P1476
Improving compliance and persistence with bisphosphonate therapy for osteoporosis.
@en
P2093
Mark Ettinger
Ronald D Emkey
P304
P356
10.1016/J.AMJMED.2005.12.019
P407
P433
P577
2006-04-01T00:00:00Z